Skip to main content
Fachkrankenhaus Coswig on Muck Rack

Fachkrankenhaus Coswig

As seen in: The Lancet, kma Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fachkrankenhaus

Contact Fachkrankenhaus, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Status of Pulmonary Metastasectomy After PuLMiCC Trial: A Survey Amongst Oncologists, Gynecologists, Urologists and Dermatologists on Medical Needs for Local Therapy

|
By Daniel Baum, Fachkrankenhaus Coswig, Markus Gräfe, Rahel Decker
| tu-dresden.de
Background: The role of pulmonary metastasectomy has been increasingly questioned in the surgical community after the PulMiCC trial challenged its benefit in colorectal cancer. However, the view on pulmonary metastasectomy among people in non-surgical disciplines remains unclear. This study explored interdisciplinary attitudes toward pulmonary metastasectomy and identified the clinical expectations shaping its future role.
Open in Who Shared Issue with article?

Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019

|
By Katrin Milger, Dirk Koschel, Fachkrankenhaus Coswig, Dirk Skowasch
| tu-dresden.de
PURPOSE: Asthma is affecting 4-5% of all adults (10% of children) in Germany, ≥ half are inadequately controlled. In 2019 up to 54 thousand patients suffered from severe uncontrolled asthma, 52% were treated/co-treated by pneumonologists. 45% of them had continuous oral corticosteroid (OCS)- and short-acting β2-agonist (SABA) overuse for ≥2 years. The aim of the current study was to analyze the main treatments, escalation schemes and the adherence to the GINA recommendations.
Open in Who Shared Issue with article?

Fachkrankenhaus: Torsten Bochannek wird neuer Geschäftsführer in Coswig

|
By Fachkrankenhaus Coswig
| kma Online Verified
Ab 1. Januar 2023 ist Torsten Bochannek neuer Geschäftsführer des Fachkrankenhauses Coswig. Damit folgt er auf Viktor Helmers, der zum selben Tag als neuer Geschäftsführer im Dresdner St. Joseph-Stift startet. Das Fachkrankenhaus Coswig bekommt ab 2023 mit Torsten Bochannek einen neuen Geschäftsführer, welcher neben seiner Rolle als Geschäftsführer der Lungenfachklinik auch die Leitung in den im Gesundheitszentrum Recura betriebenen ambulanten Einrichtungen in Sachsen übernimmt.
Open in Who Shared Issue with article?
See all 7 articles